News England's new-look Cancer Drugs Fund begins But concerns remain about access to oncology medicines.
Views & Analysis Access to cancer drugs: planning for every outcome New UK oncology drug assessment procedures examined.
News Vertex seeks deal after NICE rejects CF drug Orkambi Company in talks with NICE over patient access scheme.
News Duchenne drug available in England within weeks after NICE a... NHS England struck deal speeding access to drug.
News Scotland's Opdivo decision sparks funding row Patients in Scotland will receive lung cancer drug, those in England will not.
News Novo Nordisk gets FDA okay for Wegovy pill The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of its Wegovy pill.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
